NCT03981770View on ClinicalTrials.gov

Characterisation of Gut Microbiota, Bispectral Index Data and Plasma Kynurenine in Patients Undergoing Thyroid Surgery

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

January 17, 2020

Conditions
Sleep Deprivation
Interventions
DRUG

General anesthesia

For maintenance of propofol anesthesia, total intravenous anesthesia was administered by using propofol (Fresenius Kabi, Austria GmbH) at a plasma target concentration (Marsh pharmacokinetic model software) of 2.5-4 μg/ml. Remifentanil (0.2-0.5 μg/kg/min) was given to all patients during the operation.

Trial Locations (1)

110001

the First Hospital of China Medical University, Shenyang

All Listed Sponsors
lead

China Medical University, China

OTHER

NCT03981770 - Characterisation of Gut Microbiota, Bispectral Index Data and Plasma Kynurenine in Patients Undergoing Thyroid Surgery | Biotech Hunter | Biotech Hunter